Prostate Tumor-Derived GDF11 Accelerates Androgen Deprivation Therapy-Induced Sarcopenia

JCI insight - United States
doi 10.1172/jci.insight.127018
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Androgen Deprivation Therapy for Prostate Cancer

2017English

Does Use of Androgen Deprivation Therapy (ADT) in Men With Prostate Cancer Increase the Risk of Sarcopenia?

Calcified Tissue International
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2019English

Evolving Use of Androgen Deprivation Therapy in Prostate Cancer Management

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2016English

Androgen Deprivation Therapy for Prostate Cancer and Risk of Dementia

BJU International
Urology
2019English

Androgen Deprivation Therapy as Backbone Therapy in the Management of Prostate Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Adaptive Phenotype Drives Resistance to Androgen Deprivation Therapy in Prostate Cancer

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2017English

Use of Androgen Deprivation Therapy in Prostate Cancer: Indications and Prevalence

Asian Journal of Andrology
MedicineUrology
2012English

Cardiovascular and Metabolic Effects of Androgen-Deprivation Therapy for Prostate Cancer

Journal of Oncology Practice
Health PolicyOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy